Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01503034

Completed

Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014

Breast Cancer
NCT02567929

Completed

Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer

Breast Cancer
NCT01706016

Completed

Local Treatment by Thermic Destruction of Primitive Breast Cancer (LASERBREAST1)

Breast Cancer
NCT01366248

Completed

Integrative Oncology Outcomes Study in Breast Cancer (IO-OS-BC)

Breast Cancer
NCT03065010

Completed

Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer

Breast Cancer
NCT01515800

Completed

S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer

Breast Cancer
NCT00089973

Completed

Study Of Ispinesib In Subjects With Breast Cancer

Neoplasms, Breast
NCT02120417

Terminated

A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer

Breast Cancer
NCT02527317

Completed

Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer

Breast Cancer
NCT01484041

Terminated

Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

Breast Cancer
NCT02784730

Withdrawn

Iterative PICC Placement Versus Long Term Device (PICC One Day)

Breast Cancer
NCT03419026

Completed

Pregnant Exposure to Persistent Organic Pollutants

Breast Cancer
NCT03126487

Withdrawn

High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer (MRHEATBREAST)

Breast Cancer
NCT00882596

Completed

Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients

Breast Cancer
NCT00950300

Completed

A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer

Breast Cancer
NCT01695226

Completed

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

Breast Cancer | Breast Neoplasms
NCT02108561

Unknown

Breast Cancer Tumor Heterogeneity

Breast Cancer
NCT03390608

Completed

Prognostic and Predictive Factors for Small Breast Tumors

Breast Cancer
NCT00009945

Completed

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Breast Cancer
NCT00373152

Withdrawn

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Breast Cancer
NCT01009437

Completed

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Breast Cancer
NCT00656019

Completed

Development of Vitamin D as a Therapy for Breast Cancer - Phase 2

Breast Cancer
NCT03347864

Unknown

68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients

Breast Tumor
NCT00169533

Completed

Rollover Study Of Lapatinib In Cancer Patients

Neoplasms, Breast
NCT00650910

Completed

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Neoplasms, Breast
NCT00849329

Completed

A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer

Neoplasms, Breast
NCT00622401

Terminated

Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12

Breast Cancer
NCT00359190

Completed

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Neoplasms, Breast
NCT01046929

Completed

Limonene Study in Women With Breast Cancer

Breast Cancer
NCT03069261

Completed

Intraoperative Indocyanine Green Laser Angiography; Postoperative Outcomes for Autologous Tissue Flaps

Breast Cancer
NCT02017496

Terminated

Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment (NeoBCT)

Breast Cancer
NCT02625935

Completed

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Breast Cancer
NCT02480218

Completed

Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women

Breast Cancer
NCT02286362

Completed

An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer

Breast Cancer
NCT02768714

Withdrawn

Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy

Breast Cancer
NCT03282812

Completed

Metabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition Cohort

Breast Cancer
NCT00535418

Completed

Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

Breast Cancer
NCT01661153

Completed

An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer

Breast Cancer
NCT01603303

Completed

Preventing Sexual Dysfunction With Aromatase Inhibitors

Breast Cancer
NCT02074878

Terminated

CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer (CRIZENT)

Breast Cancer
NCT02549430

Completed

To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy (TREnd)

Breast Cancer
NCT00206492

Terminated

Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

Breast Cancer
NCT00783757

Completed

TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer

Breast Cancer
NCT02040493

Terminated

Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer

Breast Cancer
NCT00041470

Terminated

Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial

Breast Cancer
NCT02569294

Completed

Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being (GIBC)

Breast Cancer
NCT02496065

Completed

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

Tumors, Breast
NCT00008346

Completed

Digital Mammography Screening Trial (ACRIN6652) (DMIST)

Breast Cancer
NCT03211572

Unknown

The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers (OTT 17-01)

Breast Cancer
NCT01830244

Unknown

IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer (Neonab)

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations